AMRN
Amarin Corporation PLC
NASDAQ: AMRN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$12.75
+6.65% today
Updated 2026-10-28
Market cap
$239.11M
P/E ratio
—
P/S ratio
1.28x
EPS (TTM)
$-1.20
Dividend yield
—
52W range
$11 – $21
Volume
0.1M
Amarin Corporation PLC (AMRN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$12.75
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$109.11
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.6B | $0.4B | $0.3B | $0.2B | $0.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -14.60%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.